Financhill
Buy
66

ISRG Quote, Financials, Valuation and Earnings

Last price:
$489.55
Seasonality move :
14.6%
Day range:
$442.90 - $529.19
52-week range:
$364.17 - $616.00
Dividend yield:
0%
P/E ratio:
81.58x
P/S ratio:
22.67x
P/B ratio:
11.35x
Volume:
6M
Avg. volume:
2.8M
1-year change:
33.76%
Market cap:
$186.5B
Revenue:
$8.4B
EPS (TTM):
$6.41

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ISRG
Intuitive Surgical
$2.2B $1.73 15.6% 34.96% $619.74
ABT
Abbott Laboratories
$10.4B $1.07 5.86% 68.83% $136.47
BSX
Boston Scientific
$4.6B $0.67 16.07% 222.09% $115.37
IART
Integra Lifesciences Holdings
$381.2M $0.43 3.33% 241.78% $25.63
SYK
Stryker
$5.7B $2.73 8.46% 47.47% $423.15
TFX
Teleflex
$699.4M $2.88 1.37% 104.93% $165.22
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ISRG
Intuitive Surgical
$522.95 $619.74 $186.5B 81.58x $0.00 0% 22.67x
ABT
Abbott Laboratories
$127.04 $136.47 $220.3B 16.61x $0.59 1.76% 5.29x
BSX
Boston Scientific
$96.77 $115.37 $142.8B 77.42x $0.00 0% 8.59x
IART
Integra Lifesciences Holdings
$19.19 $25.63 $1.5B 70.14x $0.00 0% 0.92x
SYK
Stryker
$362.97 $423.15 $138.5B 46.77x $0.84 0.9% 6.19x
TFX
Teleflex
$135.16 $165.22 $6.3B 95.18x $0.34 1.01% 2.09x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ISRG
Intuitive Surgical
-- 1.907 -- 3.08x
ABT
Abbott Laboratories
22.86% 0.777 7.72% 1.23x
BSX
Boston Scientific
32.79% 0.797 8.05% 0.46x
IART
Integra Lifesciences Holdings
53.85% 2.157 103.03% 0.59x
SYK
Stryker
39.72% 1.207 10.13% 1.11x
TFX
Teleflex
27.91% 0.883 20.11% 1.15x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ISRG
Intuitive Surgical
$1.6B $734.9M 15.6% 15.6% 30.45% $510.6M
ABT
Abbott Laboratories
$6B $1.9B 24.06% 32.63% 19.74% $2.1B
BSX
Boston Scientific
$3.1B $790M 5.97% 8.96% 14.58% $1.2B
IART
Integra Lifesciences Holdings
$249.1M $35.6M -0.21% -0.45% 9.38% $11.2M
SYK
Stryker
$4.2B $1.6B 9.04% 15.22% 24.21% $1.7B
TFX
Teleflex
$439.9M $140.8M 1.13% 1.57% -13.59% $170.4M

Intuitive Surgical vs. Competitors

  • Which has Higher Returns ISRG or ABT?

    Abbott Laboratories has a net margin of 28.41% compared to Intuitive Surgical's net margin of 84.1%. Intuitive Surgical's return on equity of 15.6% beat Abbott Laboratories's return on equity of 32.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    68.04% $1.88 $16.5B
    ABT
    Abbott Laboratories
    54.97% $5.27 $62B
  • What do Analysts Say About ISRG or ABT?

    Intuitive Surgical has a consensus price target of $619.74, signalling upside risk potential of 18.51%. On the other hand Abbott Laboratories has an analysts' consensus of $136.47 which suggests that it could grow by 7.43%. Given that Intuitive Surgical has higher upside potential than Abbott Laboratories, analysts believe Intuitive Surgical is more attractive than Abbott Laboratories.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 10 0
    ABT
    Abbott Laboratories
    13 7 0
  • Is ISRG or ABT More Risky?

    Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.803, suggesting its less volatile than the S&P 500 by 19.666%.

  • Which is a Better Dividend Stock ISRG or ABT?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 1.76% to investors and pays a quarterly dividend of $0.59 per share. Intuitive Surgical pays -- of its earnings as a dividend. Abbott Laboratories pays out 28.62% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ISRG or ABT?

    Intuitive Surgical quarterly revenues are $2.4B, which are smaller than Abbott Laboratories quarterly revenues of $11B. Intuitive Surgical's net income of $685.7M is lower than Abbott Laboratories's net income of $9.2B. Notably, Intuitive Surgical's price-to-earnings ratio is 81.58x while Abbott Laboratories's PE ratio is 16.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 22.67x versus 5.29x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    22.67x 81.58x $2.4B $685.7M
    ABT
    Abbott Laboratories
    5.29x 16.61x $11B $9.2B
  • Which has Higher Returns ISRG or BSX?

    Boston Scientific has a net margin of 28.41% compared to Intuitive Surgical's net margin of 12.41%. Intuitive Surgical's return on equity of 15.6% beat Boston Scientific's return on equity of 8.96%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    68.04% $1.88 $16.5B
    BSX
    Boston Scientific
    67.86% $0.38 $32.6B
  • What do Analysts Say About ISRG or BSX?

    Intuitive Surgical has a consensus price target of $619.74, signalling upside risk potential of 18.51%. On the other hand Boston Scientific has an analysts' consensus of $115.37 which suggests that it could grow by 19.22%. Given that Boston Scientific has higher upside potential than Intuitive Surgical, analysts believe Boston Scientific is more attractive than Intuitive Surgical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 10 0
    BSX
    Boston Scientific
    23 5 0
  • Is ISRG or BSX More Risky?

    Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.728, suggesting its less volatile than the S&P 500 by 27.188%.

  • Which is a Better Dividend Stock ISRG or BSX?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ISRG or BSX?

    Intuitive Surgical quarterly revenues are $2.4B, which are smaller than Boston Scientific quarterly revenues of $4.6B. Intuitive Surgical's net income of $685.7M is higher than Boston Scientific's net income of $566M. Notably, Intuitive Surgical's price-to-earnings ratio is 81.58x while Boston Scientific's PE ratio is 77.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 22.67x versus 8.59x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    22.67x 81.58x $2.4B $685.7M
    BSX
    Boston Scientific
    8.59x 77.42x $4.6B $566M
  • Which has Higher Returns ISRG or IART?

    Integra Lifesciences Holdings has a net margin of 28.41% compared to Intuitive Surgical's net margin of 4.39%. Intuitive Surgical's return on equity of 15.6% beat Integra Lifesciences Holdings's return on equity of -0.45%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    68.04% $1.88 $16.5B
    IART
    Integra Lifesciences Holdings
    56.27% $0.25 $3.3B
  • What do Analysts Say About ISRG or IART?

    Intuitive Surgical has a consensus price target of $619.74, signalling upside risk potential of 18.51%. On the other hand Integra Lifesciences Holdings has an analysts' consensus of $25.63 which suggests that it could grow by 33.53%. Given that Integra Lifesciences Holdings has higher upside potential than Intuitive Surgical, analysts believe Integra Lifesciences Holdings is more attractive than Intuitive Surgical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 10 0
    IART
    Integra Lifesciences Holdings
    2 5 2
  • Is ISRG or IART More Risky?

    Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Integra Lifesciences Holdings has a beta of 1.241, suggesting its more volatile than the S&P 500 by 24.12%.

  • Which is a Better Dividend Stock ISRG or IART?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra Lifesciences Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Integra Lifesciences Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ISRG or IART?

    Intuitive Surgical quarterly revenues are $2.4B, which are larger than Integra Lifesciences Holdings quarterly revenues of $442.6M. Intuitive Surgical's net income of $685.7M is higher than Integra Lifesciences Holdings's net income of $19.4M. Notably, Intuitive Surgical's price-to-earnings ratio is 81.58x while Integra Lifesciences Holdings's PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 22.67x versus 0.92x for Integra Lifesciences Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    22.67x 81.58x $2.4B $685.7M
    IART
    Integra Lifesciences Holdings
    0.92x 70.14x $442.6M $19.4M
  • Which has Higher Returns ISRG or SYK?

    Stryker has a net margin of 28.41% compared to Intuitive Surgical's net margin of 8.48%. Intuitive Surgical's return on equity of 15.6% beat Stryker's return on equity of 15.22%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    68.04% $1.88 $16.5B
    SYK
    Stryker
    64.85% $1.41 $34.2B
  • What do Analysts Say About ISRG or SYK?

    Intuitive Surgical has a consensus price target of $619.74, signalling upside risk potential of 18.51%. On the other hand Stryker has an analysts' consensus of $423.15 which suggests that it could grow by 16.58%. Given that Intuitive Surgical has higher upside potential than Stryker, analysts believe Intuitive Surgical is more attractive than Stryker.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 10 0
    SYK
    Stryker
    13 9 0
  • Is ISRG or SYK More Risky?

    Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Stryker has a beta of 0.929, suggesting its less volatile than the S&P 500 by 7.107%.

  • Which is a Better Dividend Stock ISRG or SYK?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stryker offers a yield of 0.9% to investors and pays a quarterly dividend of $0.84 per share. Intuitive Surgical pays -- of its earnings as a dividend. Stryker pays out 40.73% of its earnings as a dividend. Stryker's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ISRG or SYK?

    Intuitive Surgical quarterly revenues are $2.4B, which are smaller than Stryker quarterly revenues of $6.4B. Intuitive Surgical's net income of $685.7M is higher than Stryker's net income of $546M. Notably, Intuitive Surgical's price-to-earnings ratio is 81.58x while Stryker's PE ratio is 46.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 22.67x versus 6.19x for Stryker. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    22.67x 81.58x $2.4B $685.7M
    SYK
    Stryker
    6.19x 46.77x $6.4B $546M
  • Which has Higher Returns ISRG or TFX?

    Teleflex has a net margin of 28.41% compared to Intuitive Surgical's net margin of -17.18%. Intuitive Surgical's return on equity of 15.6% beat Teleflex's return on equity of 1.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    68.04% $1.88 $16.5B
    TFX
    Teleflex
    55.31% -$2.95 $5.9B
  • What do Analysts Say About ISRG or TFX?

    Intuitive Surgical has a consensus price target of $619.74, signalling upside risk potential of 18.51%. On the other hand Teleflex has an analysts' consensus of $165.22 which suggests that it could grow by 22.24%. Given that Teleflex has higher upside potential than Intuitive Surgical, analysts believe Teleflex is more attractive than Intuitive Surgical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 10 0
    TFX
    Teleflex
    0 11 0
  • Is ISRG or TFX More Risky?

    Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Teleflex has a beta of 1.191, suggesting its more volatile than the S&P 500 by 19.095%.

  • Which is a Better Dividend Stock ISRG or TFX?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Teleflex offers a yield of 1.01% to investors and pays a quarterly dividend of $0.34 per share. Intuitive Surgical pays -- of its earnings as a dividend. Teleflex pays out 91.2% of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ISRG or TFX?

    Intuitive Surgical quarterly revenues are $2.4B, which are larger than Teleflex quarterly revenues of $795.4M. Intuitive Surgical's net income of $685.7M is higher than Teleflex's net income of -$136.7M. Notably, Intuitive Surgical's price-to-earnings ratio is 81.58x while Teleflex's PE ratio is 95.18x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 22.67x versus 2.09x for Teleflex. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    22.67x 81.58x $2.4B $685.7M
    TFX
    Teleflex
    2.09x 95.18x $795.4M -$136.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Realty Income the Best Dividend Stock to Buy Long-Term?
Is Realty Income the Best Dividend Stock to Buy Long-Term?

Realty Income (NYSE:O) is a longstanding real estate investment trust…

Is Archer Aviation a Buy, Sell or Hold?
Is Archer Aviation a Buy, Sell or Hold?

Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…

Down 50%, Is Dell Technologies a Buy?
Down 50%, Is Dell Technologies a Buy?

Dell (NYSE:DELL)’s share price has been on a roller coaster…

Stock Ideas

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
33
BULZ alert for Apr 10

MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 15.35% over the past day.

Sell
31
TECS alert for Apr 10

Direxion Daily Technology Bear 3x Shares [TECS] is up 12.66% over the past day.

Sell
48
FNGA alert for Apr 10

MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 13.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock